ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 141 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 2.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $566,000 | +62.2% | 30,017 | +17.3% | 0.01% | +25.0% |
| Q1 2019 | $349,000 | -12.5% | 25,596 | -34.3% | 0.00% | -20.0% |
| Q4 2018 | $399,000 | -46.4% | 38,953 | -12.9% | 0.01% | -44.4% |
| Q3 2018 | $745,000 | +97.1% | 44,735 | +86.7% | 0.01% | +80.0% |
| Q2 2018 | $378,000 | -80.9% | 23,955 | -84.6% | 0.01% | -83.9% |
| Q1 2018 | $1,978,000 | +451.0% | 155,711 | +396.6% | 0.03% | +416.7% |
| Q4 2017 | $359,000 | -21.8% | 31,358 | +125.6% | 0.01% | -88.0% |
| Q4 2015 | $459,000 | +37.4% | 13,900 | +120.6% | 0.05% | -53.7% |
| Q2 2015 | $334,000 | – | 6,300 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,203 | $36,042,000 | 9.93% |
| Foresite Capital Management II, LLC | 1,043,832 | $12,787,000 | 5.18% |
| Redmile Group, LLC | 6,476,766 | $79,340,000 | 3.91% |
| DAFNA Capital Management LLC | 346,013 | $4,239,000 | 2.63% |
| Cormorant Asset Management, LP | 900,000 | $11,025,000 | 1.95% |
| SENZAR ASSET MANAGEMENT, LLC | 641,170 | $7,854,000 | 1.92% |
| Asymmetry Capital Management, L.P. | 105,228 | $1,289,000 | 1.50% |
| New Leaf Venture Partners, L.L.C. | 171,364 | $2,099,000 | 0.97% |
| EMERALD ADVISERS, LLC | 1,578,477 | $19,336,000 | 0.79% |
| BB BIOTECH AG | 2,266,008 | $27,759,000 | 0.77% |